Jacques Dreyfuss

1.2k total citations
36 papers, 958 citations indexed

About

Jacques Dreyfuss is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Jacques Dreyfuss has authored 36 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Pharmacology and 8 papers in Oncology. Recurrent topics in Jacques Dreyfuss's work include Phenothiazines and Benzothiazines Synthesis and Activities (8 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Drug Transport and Resistance Mechanisms (7 papers). Jacques Dreyfuss is often cited by papers focused on Phenothiazines and Benzothiazines Synthesis and Activities (8 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Drug Transport and Resistance Mechanisms (7 papers). Jacques Dreyfuss collaborates with scholars based in United States, Malaysia and Switzerland. Jacques Dreyfuss's co-authors include Kenneth J. Monty, Arthur B. Pardee, Eric C. Schreiber, James M. Shaw, Louise S. Prestidge, John J. Ross, Allen I. Cohen, J. Thomas Bigger, DA Willard and Elsa‐Grace V. Giardina and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Bacteriology and Journal of Medicinal Chemistry.

In The Last Decade

Jacques Dreyfuss

34 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacques Dreyfuss United States 16 410 114 114 109 103 36 958
K. Pfleger Germany 20 416 1.0× 129 1.1× 276 2.4× 39 0.4× 79 0.8× 110 1.4k
Charles E. Hignite United States 19 838 2.0× 165 1.4× 133 1.2× 152 1.4× 113 1.1× 38 1.9k
Masayoshi Yoshikawa Japan 15 238 0.6× 104 0.9× 38 0.3× 128 1.2× 29 0.3× 60 878
Mikio Masada Japan 20 315 0.8× 208 1.8× 71 0.6× 80 0.7× 106 1.0× 77 1.3k
M. Kraml United States 18 396 1.0× 201 1.8× 89 0.8× 71 0.7× 30 0.3× 66 1.2k
Joachim Fauler Germany 18 185 0.5× 138 1.2× 90 0.8× 184 1.7× 33 0.3× 40 1.0k
Jeremy D. Hribar United States 13 319 0.8× 230 2.0× 47 0.4× 80 0.7× 50 0.5× 24 975
Joachim Ziegenhorn United States 13 358 0.9× 81 0.7× 13 0.1× 74 0.7× 206 2.0× 22 1.5k
Jörgen Vessman Sweden 23 205 0.5× 138 1.2× 446 3.9× 29 0.3× 24 0.2× 85 1.6k
Toshiaki Miura Japan 19 320 0.8× 141 1.2× 22 0.2× 38 0.3× 95 0.9× 66 1.1k

Countries citing papers authored by Jacques Dreyfuss

Since Specialization
Citations

This map shows the geographic impact of Jacques Dreyfuss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Dreyfuss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Dreyfuss more than expected).

Fields of papers citing papers by Jacques Dreyfuss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Dreyfuss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Dreyfuss. The network helps show where Jacques Dreyfuss may publish in the future.

Co-authorship network of co-authors of Jacques Dreyfuss

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Dreyfuss. A scholar is included among the top collaborators of Jacques Dreyfuss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Dreyfuss. Jacques Dreyfuss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beglinger, Christoph, W. Born, Roman Muff, et al.. (1992). Intracolonic bioavailability of human calcitonin in man. European Journal of Clinical Pharmacology. 43(5). 527–531. 20 indexed citations
2.
Dreyfuss, Jacques, S. M. Singhvi, James M. Shaw, et al.. (1979). Metabolism of tritium- and carbon-14-labeled tiamulin in dogs, rats, and pigs.. The Journal of Antibiotics. 32(5). 496–503. 3 indexed citations
3.
Dreyfuss, Jacques, James M. Shaw, & John J. Ross. (1978). Absorption of the β-Adrenergic-Blocking Agent, Nadolol, by Mice, Rats, Hamsters, Rabbits, Dogs, Monkeys, and Man: An Unusual Species Difference. Xenobiotica. 8(8). 503–508. 21 indexed citations
4.
Dreyfuss, Jacques, et al.. (1977). Metabolic Studies in Patients with Nadolol: Oral and Intravenous Administration. The Journal of Clinical Pharmacology. 17(5-6). 300–307. 63 indexed citations
5.
Dreyfuss, Jacques, et al.. (1977). Nadolol: Placental transfer and excretion in the milk of rats. Toxicology and Applied Pharmacology. 39(2). 275–282. 9 indexed citations
6.
Giardina, Elsa‐Grace V., Jacques Dreyfuss, J. Thomas Bigger, James M. Shaw, & Eric C. Schreiber. (1976). Metabolism of procainamide in normal and cardiac subjects. Clinical Pharmacology & Therapeutics. 19(3). 339–351. 57 indexed citations
7.
Dreyfuss, Jacques, et al.. (1975). Absorption and biotransformation of topically applied 8-(methylthio)cyclic AMP. British Journal of Dermatology. 93(4). 379–390.
8.
Dreyfuss, Jacques, et al.. (1973). Distribution of Dibenzoxazepines Bearing the Carboxamide or Other Side Chains in Ocular and Other Tissues of Dogs. Journal of Pharmaceutical Sciences. 62(4). 606–609. 1 indexed citations
9.
Dreyfuss, Jacques, J. Thomas Bigger, Allen I. Cohen, & Eric C. Schreiber. (1972). Metabolism of procainamide in rhesus monkey and man. Clinical Pharmacology & Therapeutics. 13(3). 366–371. 72 indexed citations
10.
Dreyfuss, Jacques, et al.. (1972). Fluphenazine-induced parkinsonism in the baboon: Pharmacological and metabolic studies. Neuropharmacology. 11(2). 223–230. 6 indexed citations
11.
Dreyfuss, Jacques & Allen I. Cohen. (1971). Identification of 7-Hydroxyfluphenazine as Major Metabolite of Fluphenazine-14C in the Dog. Journal of Pharmaceutical Sciences. 60(6). 826–828. 14 indexed citations
12.
Wong, Keith, et al.. (1971). Absorption, Excretion, and Biotransformation of Dimethyl Sulfoxide in Man and Miniature Pigs After Topical Application as an 80% Gel. Journal of Investigative Dermatology. 56(1). 44–48. 24 indexed citations
13.
Dreyfuss, Jacques, John J. Ross, & Eric C. Schreiber. (1971). Excretion and Biotransformation of the Enanthate Ester of Fluphenazine-14C by the Dog. Journal of Pharmaceutical Sciences. 60(6). 829–833. 11 indexed citations
14.
Dreyfuss, Jacques, et al.. (1971). Metabolism in Dogs of the Chloro- and Trifluoromethyl-Analogues of a Piperazine-substituted Dihydrobenzoxazepine. Xenobiotica. 1(1). 29–41. 6 indexed citations
15.
Dreyfuss, Jacques, et al.. (1971). Metabolism of sodium tosylate-35S by rats and dogs. Toxicology and Applied Pharmacology. 20(4). 548–551. 2 indexed citations
16.
Dreyfuss, Jacques, et al.. (1970). Excretion and metabolism of cinanserin-14C and its oxygen analogue, SQ 10, 624-14C. European Journal of Pharmacology. 11(2). 254–262. 2 indexed citations
17.
Dreyfuss, Jacques, Allen I. Cohen, & Sidney M. Hess. (1968). Metabolism of Thiazesim, 5-(2-Dimethylaminoethyl)-2,3-dihydro-2-phenyl-1,5-benzothiazepin-4(5H)-one, in the Rat In Vivo and In Vitro. Journal of Pharmaceutical Sciences. 57(9). 1505–1511. 5 indexed citations
18.
Dreyfuss, Jacques, et al.. (1968). Excretion and Distribution of Thiazesim-14C with Its Biotransformation In Vivo and In Vitro. Journal of Pharmaceutical Sciences. 57(9). 1497–1505. 3 indexed citations
19.
Dreyfuss, Jacques & Arthur B. Pardee. (1966). Regulation of Sulfate Transport in Salmonella typhimurium. Journal of Bacteriology. 91(6). 2275–2280. 52 indexed citations
20.
Dreyfuss, Jacques, et al.. (1964). METABOLIC REGULATION OF ADENOSINE TRIPHOSPHATE SULFURYLASE IN YEAST. Journal of Bacteriology. 88(5). 1341–1348. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026